scholarly journals Breast cancer and pyoderma gangrenosum: a complication after conservative surgery and radiotherapy

Mastology ◽  
2020 ◽  
Vol 30 ◽  
Author(s):  
Flávia Kuroda ◽  
Cicero Urban ◽  
Erica Mendes ◽  
Anelise Rocha Raymundo ◽  
Alessandra Amatuzzi Cordeiro Fornazari ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Diagnosis ◽  
Pyoderma Gangrenosum ◽  
Adjuvant Radiotherapy ◽  
Treatment Effectiveness ◽  
Conservative Surgery ◽  
Neutrophilic Dermatosis ◽  
Systemic Diseases ◽  
Pathergy Phenomenon

Pyoderma gangrenosum (PG) is a rare, ulcerative, and painful neutrophilic dermatosis of unknown cause associated with systemic diseases and/or pathergy phenomenon in 30% of cases. We report the case of a breast cancer patient submitted to oncoplastic conservative surgery followed by adjuvant radiotherapy, with long-term progression to PG. It’s rare and challeng ing nature reinforces the need for early diagnosis to increase treatment effectiveness and reduce morbidity.

scholarly journals Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer

2005 ◽  
Vol 41 (17) ◽  
pp. 2637-2644 ◽  
Author(s):  
A.C. Voogd ◽  
F.J. van Oost ◽  
E.J.T. Rutgers ◽  
P.H.M. Elkhuizen ◽  
A.N. van Geel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Recurrence ◽  
Early Breast Cancer ◽  
Conservative Surgery ◽  
Long Term Prognosis

Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment

2012 ◽  
Vol 14 (12) ◽  
pp. 953-960 ◽  
Author(s):  
Aurora Rodríguez Pérez ◽  
Maria Concepción López Carrizosa ◽  
Pilar Maria Samper Ots ◽  
José Fermín Pérez-Regadera Gómez ◽  
José Zapatero Ortuño ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Conservative Surgery ◽  
Hdr Brachytherapy ◽  
External Radiotherapy ◽  
Single Fraction

scholarly journals Pyoderma Gangrenosum with Positive Antinuclear Antibody, in the Absence of Systemic Association

2018 ◽  
Vol 16 (1) ◽  
pp. 66-69
Author(s):  
Smriti Shrestha ◽  
Alisha Aryal
Keyword(s):  
Pyoderma Gangrenosum ◽  
Lupus Erythematosus ◽  
Antinuclear Antibody ◽  
Case Reports ◽  
Neutrophilic Dermatosis ◽  
Systemic Diseases ◽  
Connective Tissue Disorders ◽  
Systemic Lupus ◽  
Unique Case ◽  
Positive Antinuclear Antibody

Pyoderma gangrenosum is an uncommon neutrophilic dermatosis, seen on legs, and infrequently on hands and other anatomical sites. It is associated with systemic diseases in 50-70% of the cases. Antinuclear antibody (ANA) seropositivity has been reported in pyoderma gangrenosum associated with connective tissue disorders. However, there are very few case reports of pyoderma gangrenosum in patients of systemic lupus erythematosus, while we did not find any reports of ANA seropositivity in isolated pyoderma gangrenosum. Hence, we report this unique case of pyoderma gangrenosum with classical clinicohistopathology, positive ANA but no systemic association. As anticipated, our patient responded promptly to steroids.

Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: A retrospective analysis

2012 ◽  
Vol 55 (2) ◽  
pp. 283-288 ◽  
Author(s):  
Francesco Fiorica ◽  
Massimiliano Berretta ◽  
Stefano Ursino ◽  
Rossella Fisichella ◽  
Arben Lleshi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Retrospective Analysis ◽  
Cancer Patients ◽  
Adjuvant Radiotherapy ◽  
Conservative Surgery ◽  
Breast Cancer Patients

scholarly journals Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

1999 ◽  
Vol 15 (1-3) ◽  
pp. 207-211 ◽  
Author(s):  
P. Møller ◽  
G. Evans ◽  
N. Haites ◽  
H. Vasen ◽  
M. M. Reis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Early Diagnosis ◽  
Brca1 Mutation ◽  
Breast Cancers ◽  
Management Options ◽  
Detection Rates ◽  
Inherited Breast Cancer

Protocols for activity aiming at early diagnosis and treatment of inherited breast or breast-ovarian cancer have been reported. Available reports on outcome of such programmes are considered here. It is concluded that the ongoing activities should continue with minor modifications. Direct evidence of a survival benefit from breast and ovarian screening is not yet available. On the basis of expert opinion and preliminary results from intervention programmes indicating good detection rates for early breast cancers and 5-year survival concordant with early diagnosis, we propose that women at high risk for inherited breast cancer be offered genetic counselling, education in ‘breast awareness’ and annual mammography and clinical expert examination from around 30 years of age. Mammography every second year may be sufficient from 60 years on. BRCA1 mutation carriers may benefit from more frequent examinations and cancer risk may be reduced by oophorectomy before 40–50 years of age. We strongly advocate that all activities should be organized as multicentre studies subjected to continuous evaluation to measure the effects of the interventions on long-term mortality, to match management options more precisely to individual risks and to prepare the ground for studies on chemoprevention.

Sign in / Sign up

Export Citation Format

Share Document